Between June and September 2025, Lumera fielded a structured shopper study across six Indian cities: 14,200 completed interviews, split between store-exit interviews, household panels and a diary sub-study of 1,100 protein-claim purchasers. The trigger was obvious to anyone walking a supermarket aisle. Protein claims on Indian packaged-food SKUs have tripled since 2022, from atta to bhujia to cold coffee. Somebody must be buying all of it. We went and asked them why.
The headline number first: stated willingness to pay a protein premium is real but radically uneven across categories. For staple foods — atta, milk, dosa batter — the premium ceiling is about 11 percent. For snacking and beverages it is 26 percent. Brand teams consistently assume the reverse, on the theory that staples are bought on nutrition and snacks on impulse. The evidence says snacks are where protein is doing commercial work, precisely because a protein claim converts a guilty purchase into a permitted one.
The permission economy of the snack aisle
The diary sub-study is where this becomes visible. Households that bought protein-claimed biscuits, namkeen or shakes described the purchase in moral vocabulary — 'better for the kids', 'at least it's not empty calories' — at four times the rate of staple purchasers. Protein on a snack is not a macro-nutrient decision. It is an indulgence tax rebate, and it is worth a quarter higher price point.
Shoppers are not buying protein. They are buying the permission that protein gives them, and permission is a pricing lever staples have never had.
The trust numbers should worry the industry more than they apparently do. Fifty-eight percent of our respondents doubt that protein-claimed products contain the stated amount in a form that matters. Only 12 percent could correctly identify what '10 grams of protein per serve' means relative to daily needs. The claim is operating as a vibe — a powerful, premium-priced vibe — and vibes in food categories have a history of collapsing fast when a mainstream newspaper runs the exposé. Several major SKUs in our retail audit would not enjoy that headline.
Where the durable money is
Two positions look defensible. The first is staples with verifiable dosing: the brands publishing per-serve protein against ICMR reference intakes, with third-party assay, are building the only trust moat available. The second is the boring institutional channel — protein-fortified atta and edible oil into government and corporate canteen programs, where the buyer is a dietician with a spec sheet rather than a shopper with a vibe.
Everyone else is surfing a claim, and the claim will be regulated, mocked or both. The 14,200 shoppers were unambiguous about one thing: they want to be told the truth about protein, preferably by someone who treats them like adults. There is a premium for that too.
